 | Tempest Therapeutics Inc Shares Fall 2.1% Below Previous 52-Week Low - Market Mover
nasdaq.com - January 15 at 1:40 AM |
| Tempest Therapeutics Inc Shares Near 52-Week Low - Market Mover
nasdaq.com - January 12 at 10:29 AM |
 | Tempest Announces First Patient Dosed with TPST-1495 in Combination with Pembrolizumab
finance.yahoo.com - November 18 at 12:30 PM |
| Tempest Presents Data Supporting the Dual Mechanism of TPST-1495 as an Optimal Approach for Targeting the Prostaglandin Pathway in Cancer
finance.yahoo.com - November 12 at 8:54 AM |
| Tempest Reports Third Quarter 2021 Financial Results and Provides Corporate Highlights
finance.yahoo.com - November 10 at 8:16 PM |
| Tempest to Present at Two Upcoming Investor Conferences in November
finance.yahoo.com - November 9 at 8:39 AM |
| Tempest Further Bolsters Patent Portfolio with Issuance of Multiple Patents for TPST-1495
finance.yahoo.com - November 8 at 3:21 PM |
| Tempest Further Bolsters Patent Portfolio with Issuance of Multiple Patents for TPST-1495
finance.yahoo.com - November 8 at 9:05 AM |
| Tempest Announces Presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
finance.yahoo.com - October 1 at 8:32 AM |
| Tempest Announces First Patient Dosed in Randomized Study Evaluating TPST-1120 in First-Line Regimen for Hepatocellular Carcinoma in Clinical Collaboration with Roche
finance.yahoo.com - September 20 at 10:39 AM |
|
| Tempest Enters into Exclusive License Agreement with the University of California for Novel Cancer Target
finance.yahoo.com - September 13 at 6:22 PM |
| Tempest to Present at Upcoming Investor Conferences
finance.yahoo.com - September 9 at 5:39 PM |
| Tempest Reports Second Quarter 2021 Financial Results and Provides Corporate Highlights
finance.yahoo.com - August 12 at 5:33 PM |
| Tempest Announces Appointment of Ronit Simantov, M.D. to its Board of Directors
finance.yahoo.com - August 9 at 9:51 AM |
 | Tempest Therapeutics Inc.
barrons.com - August 8 at 12:28 AM |
| Tempest Therapeutics, Inc. Common Stock (TPST)
nasdaq.com - July 13 at 10:02 PM |
| 3 Health Care Stocks To Watch This Week
nasdaq.com - July 13 at 1:47 AM |
 | What's Going On With Tempest Therapeutics Stock?
msn.com - July 12 at 8:47 PM |
 | Tempest Therapeutics Inc
reuters.com - July 9 at 3:09 PM |
| Tempest to Participate in William Blair 2021 Biotech Focus Conference
finance.yahoo.com - July 9 at 10:08 AM |
 | Tempest Therapeutics, Inc. (TPST)
realmoney.thestreet.com - July 8 at 6:18 PM |
| Tempest Therapeutics Inc. (TPST)
au.finance.yahoo.com - July 3 at 6:13 AM |
| Tempest Announces Appointment of Christine Pellizzari to its Board of Directors
finance.yahoo.com - July 1 at 8:16 PM |
 | Tempest Therapeutics: Tempest Closes Merger with Millendo Therapeutics and Completes PIPE Financing
finanznachrichten.de - June 29 at 2:49 PM |
| Tempest and Millendo Announce Stockholder Approval of Merger
finance.yahoo.com - June 22 at 6:50 PM |
| Will Millendo Therapeutics (NASDAQ:MLND) Spend Its Cash Wisely?
nasdaq.com - May 5 at 3:59 PM |
| Is Millendo Therapeutics (NASDAQ:MLND) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - May 5 at 3:59 PM |
| MILLENDO ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of MLND and Encourages Investors to Contact the Firm
finance.yahoo.com - May 4 at 12:33 PM |
| MILLENDO INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Millendo Therapeutics, Inc. - MLND
finance.yahoo.com - April 8 at 12:39 AM |
| SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Millendo Therapeutics, Inc. Merger
finance.yahoo.com - April 5 at 2:26 PM |
 | SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Millendo Therapeutics, Inc. - MLND
markets.businessinsider.com - April 3 at 12:25 AM |
 | Tempest and Millendo Announce Proposed Merger Agreement - MarketWatch
marketwatch.com - March 31 at 1:15 PM |
| Millendo Therapeutics Stock Is Believed To Be Significantly Overvalued
finance.yahoo.com - March 31 at 1:15 PM |
| Millendo Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Millendo Therapeutics, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – MLND
finance.yahoo.com - March 31 at 1:15 PM |
|
| Millendo To Merge With Tempest Therapeutics; Shares Tank
finance.yahoo.com - March 30 at 12:12 PM |
| Mid-Afternoon Market Update: Dow Rises 50 Points; Orphazyme Shares Plunge
markets.businessinsider.com - March 29 at 3:42 PM |
| Mid-Morning Market Update: Markets Mostly Lower; Cal-Maine Foods Reports Mixed Q3 Results
markets.businessinsider.com - March 29 at 10:22 AM |
| Millendo To Merge With Tempest Therapeutics In An All-Stock Transaction
nasdaq.com - March 29 at 10:22 AM |
| Tempest and Millendo Announce Proposed Merger Agreement
finance.yahoo.com - March 29 at 10:22 AM |
| Millendo Therapeutics Provides Pipeline and Business Update
finance.yahoo.com - January 5 at 1:20 PM |
| Millendo Therapeutics, Inc. (3OS1.F)
in.finance.yahoo.com - December 19 at 11:54 PM |
| Is MLND A Good Stock To Buy Now?
finance.yahoo.com - December 10 at 4:48 PM |
 | Millendo Therapeutics EPS beats by $0.12
seekingalpha.com - November 9 at 11:38 AM |
| Millendo Therapeutics Reports Third Quarter 2020 Operating and Financial Results
finance.yahoo.com - November 9 at 11:37 AM |
| Millendo Therapeutics (NASDAQ:MLND) Will Have To Spend Its Cash Wisely
finance.yahoo.com - October 26 at 2:18 PM |
 | Millendo Therapeutics Announces Initiation of First-in-Human Clinical Trial of MLE-301, a Selective NK3R Antagonist | Business Wire
businesswire.com - September 25 at 11:19 AM |
| Millendo launches early-stage study of lead drug
seekingalpha.com - September 24 at 12:34 PM |
| Millendo Therapeutics commences in-human clinical trial for MLE-301
seekingalpha.com - September 24 at 12:34 PM |
| Millendo Therapeutics EPS misses by $0.01
seekingalpha.com - August 10 at 12:47 PM |
| Millendo Therapeutics Reports Second Quarter 2020 Operating and Financial Results
finance.yahoo.com - August 10 at 12:47 PM |
